Intestinal Drug Transport Enhancement by Aloe vera

Abstract

The effect of Aloe vera (L.) Burm. f. (Aloe barbadensis Miller) gel and whole leaf extract on the permeability of Caco-2 cell monolayers was determined. Solutions of gel and the whole leaf extract were applied to the cell monolayers, and the transepithelial electrical resistance was monitored for 2 hours, which was then continued for another 2 hours after removal of the test solutions to measure reversibility of the effect. The transport of insulin in the presence and absence of the A. vera gel and whole leaf extract solutions was also investigated. Both the A. vera gel and whole leaf extract were able to significantly reduce the transepithelial electrical resistance of the Caco-2 cell monolayers at concentrations above 0.5 % w/v and thereby showed the ability to open tight junctions between adjacent cells. This effect was fully reversible, as the electrical resistance of the cell monolayers returned to the original value upon removal of the test solutions. The A. vera gel and whole leaf extract solutions significantly enhanced the transport of insulin across the Caco-2 cell monolayers compared with the control. The results suggest that these plant products have a high potential to be used as absorption enhancers in novel dosage forms for drugs with poor bioavailabilities when administered orally. On the other hand, an uncontrolled increase in the bioavailability of drugs that are taken simultaneously with A. vera gel and whole leaf extract products may result in adverse effects, and the potential exists that toxic blood plasma levels may be reached.

Key words

Aloe vera (L.) Burm. f. - Asphodelaceae - gel - whole leaf extract - absorption enhancement - Caco‐2

References

• 1 Crowley P J, Martini L G. Formulation design: new drugs from old.  Drug Discov Today. 2004;  1 537-542
• 2 Gomez-Orellana I. Strategies to improve oral drug bioavailability.  Expert Opin Drug Deliv. 2005;  2 419-433
• 3 Muranishi S. Absorption enhancers.  Crit Rev Ther Drug Carrier Syst. 1990;  7 1-33
• 4 Salama N N, Eddington N D, Fasano A. Tight junction modulation and its relationship to drug delivery.  Adv Drug Deliv Rev. 2006;  58 15-28
• 5 Brayden D J, O'Mahony D J. Novel oral drug delivery gateways for biotechnology products: polypeptides and vaccines.  Pharm Sci Technol Today. 1998;  1 291-299
• 6 Newton L E. Aloes in habitat. Reynolds T, ed. Aloes: the genus Aloe. Washington DC; CRC Press 2004: 3-36
• 7 Reynolds T, Dweck A C. Aloe vera leaf gel: a review update.  J Ethnopharmacol. 1999;  68 3-37
• 8 Mascolo N, Izzo A A, Borrelli F, Capasso R, Di Carlo G, Sautebin L, Capasso F. Healing powers of aloes. Reynolds T, ed. Aloes: the genus Aloe. Washington DC; CRC Press 2004: 209-238
• 9 Talmadge J, Chavez J, Jacobs L, Munger C, Chinnah T, Chow J T, Williamson D, Yates K. Fractionation of Aloe vera L. inner gel, purification and molecular profiling of activity.  Int Immunopharmacol. 2004;  4 1757-1773
• 10 Boudreau M D, Beland F A. An evaluation of the biological and toxicological properties of Aloe barbadensis (Miller), Aloe vera.  J Environ Sci Health C. 2006;  24 103-154
• 11 Femenia A, Sanchez E S, Simal S, Rosello C. Compositional features of polysaccharides from Aloe vera (Aloe barbadensis Miller) plant tissues.  Carbohydr Polym. 1999;  39 109-117
• 12 Lee J K, Lee M K, Yun Y P. Acemannan purified from Aloe vera induces phenotypic and functional maturation of immature dendritic cells.  Int Immunopharmacol. 2001;  1 1275-1284
• 13 Moreira L RS, Filho E XF. An overview of mannan structure and mannan-degrading enzyme systems.  Appl Microbiol Biotechnol. 2008;  79 1-14
• 14 Choi S, Chung M-H. A review on the relationship between Aloe vera components and their biologic effects.  Semin Integr Med. 2003;  1 53-62
• 15 Ni Y, Turner D, Yates K M, Tizard I. Isolation and characterisation of structural components of Aloe vera L. leaf pulp.  Int Immunopharmacol. 2004;  4 1745-1755
• 16 Vinson J A, Al Kharrat H, Andreoli L. Effect of Aloe vera preparations on the human bioavailability of vitamins C and E.  Phytomedicine. 2005;  12 760-765
• 17 Cole L, Heard C H. Skin permeation enhancement potential of Aloe vera and a proposed mechanism of action based upon size exclusion and pull effect.  Int J Pharm. 2007;  333 10-16
• 18 Kotzé A F, Lueβen H L, De Leeuw B J, De Boer A G, Verhoef J C, Junginger H E. N-trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: In vitro evaluation in intestinal epithelial cells (Caco-2).  Pharm Res. 1997;  14 1197-1202
• 19 Junginger H E, Verhoef J C. Macromolecules as safe penetration enhancers for hydrophilic drugs: a fiction?.  Pharm Sci Technol Today. 1998;  9 370-376
• 20 Di Colo G, Zambito Y, Zaino C. Polymeric enhancers of mucosal epithelia permeability: synthesis, transepithelial penetration enhancement properties, mechanism of action, safety issues.  J Pharm Sci. 2007;  97 1-29
• 22 Thanou M M, Kotzé A F, Scharringhausen T, Luessen H L, De Boer A G, Verhoef J C, Junginger H E. Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal Caco-2 cell monolayers.  J Control Release. 2000;  64 15-25
• 23 Borchard G, Luessen H L, De Boer A G, Verhoef J C, Lehr C –M, Junginger H E. The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro.  J Control Release. 1996;  39 131-138
• 24 Schipper G M, Olsson S, Hoogstraate J A, De Boer A G, Varum K M, Artursson P. Chitosan as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement.  Pharm Res. 1997;  14 923-929
• 25 Grabovac V, Föger F, Bernkop-Schnürch A. Design and in vivo evaluation of a patch delivery system for insulin based on thiolated polymers.  Int J Pharm. 2008;  348 169-174
• 26 Kotzé A F, Luessen H L, De Leeuw B J, De Boer A G, Verhoef J C, Junginger H E. Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2).  J Control Release. 1998;  51 35-46